荟萃分析
结直肠癌
医学
移植
癌症
肾移植
肿瘤科
病理
内科学
作者
Bima J. Hasjim,Arsha Ostowari,Monique H Gandawidjaja,Mohsen Mohammadi,Linda Murphy,Matthew D. Whealon,Valery Vilchez,Hirohito Ichii,Robert R. Redfield,Oliver S. Eng
标识
DOI:10.1038/s41416-025-02994-7
摘要
De novo CRC was diagnosed in under 10 years after KT, and nearly 40% of patients already have advanced stage disease at diagnosis. The pooled rate of 5-year survival was 31.8%. However, there was wide heterogeneity between studies and further research is required. PROSPERO Registration: CRD42023415767.
科研通智能强力驱动
Strongly Powered by AbleSci AI